Blood clots form when blood cells and factors in the blood thicken, forming a semi-solid mass. Sometimes, if the blood clot is caused by an injury, then it is considered protective, since it will plug ...

(HealthDay News) — Deep venous thrombosis (DVT) and pulmonary embolism (PE) are uncommon after urological surgery, according to a study published in the September issue of The Journal of Urology. Mark ...

What is the best way to prevent deep vein thrombosis (DVT) or pulmonary embolism (PE) in high-risk patients? In the absence of large randomized trials, the authors performed a systematic review and ...

People who sustain a traumatic brain injury (TBI) are at high risk for developing deep vein thrombosis (DVT) and pulmonary embolism (PE). PE is a leading cause of death in these patients. But ...

FDA Approves Pradaxa® (dabigatran etexilate mesylate) for Treatment and Reduction in the Risk of Recurrence of Deep Venous Thrombosis and Pulmonary Embolism Three pivotal trials showed PRADAXA as ...

Low-dose aspirin used for the prevention of venous thromboembolism following total knee arthroplasty showed similar effects to those seen with high-dose aspirin, according to results published in The ...

Boehringer Ingelheim today announces the enrollment of the first patient in RE-COVERY DVT/PE™, a global observational study on the management of blood clots in the legs (deep vein thrombosis, DVT) and ...

Am J Health Syst Pharm. 2006;63(20):S5-S15. Patient demographics and pre-index clinical characteristics were similar between the subgroups of patients who developed DVT/PE ( Table 1). The average age ...

Functional impairment (FI) after hematopoietic cell transplantation (HCT) and impact on quality of life (QOL). Bupropion for hot flashes control in breast cancer survivors: A prospective, double-blind ...

Dual role of p21waf1/cip1 in effects of oxaliplatin (L-OHP) against colon cancer cells in p53 dependent and independent pathway Background: The most common serious adverse event associated with ...

PRINCETON, N.J. & NEW YORK, Jun 27, 2014 (BUSINESS WIRE) -- Bristol-Myers Squibb Company BMY -0.74% and Pfizer Inc. PFE -0.14% today announced that the Committee for Medicinal Products for Human Use ...

Dublin, Dec. 19, 2025 (GLOBE NEWSWIRE) -- The "Pulmonary Embolism Market - A Global and Regional Analysis, 2025-2035" has been added to ResearchAndMarkets.com's offering. The global pulmonary embolism ...